NEW YORK, NY — [February 5, 2026] — Ovarian Cancer Research Alliance (OCRA) has announced a collaboration with OPERATION WIPE OUT, an initiative that has demonstrated meaningful success reducing cervical cancer risk in Alabama through prevention-focused education and access to care. Drawing on this proven public-health framework, OCRA will adapt and expand the model nationwide—bringing practical, evidence-based cervical cancer prevention strategies to communities across the U.S.
Through this effort, OCRA’s Center for Public Policy will advance policy initiatives that support prevention, screening, and follow-up care, while OCRA will also lead a national public awareness campaign focused on the simple, effective steps that can prevent cervical cancer, including evidence-based HPV vaccination and routine screening.
From its inception, OPERATION WIPE OUT has been driven by strong partnerships. By bringing government, academia, Rotary Clubs, and partners together, we are proving that cervical cancer elimination is not just possible. it is achievable.” said Isabel Scarinci, PhD, MPH, one of the leaders of the initiative. “Partnering with OCRA allows us to build on what has worked in Alabama and accelerate its impact nationally.
This collaboration is about scaling what we know works,” said Audra Moran, President and CEO of OCRA. “OPERATION WIPE OUT has shown that focused prevention efforts can reduce cervical cancer risk in real communities. By bringing this model forward nationally—through coordinated policy leadership and public awareness—we have an opportunity to prevent disease, save lives, and move closer to eliminating cervical cancer as a public health threat.
Learn more and explore downloadable prevention resources.
About Ovarian Cancer Research Alliance (OCRA)
Ovarian Cancer Research Alliance (OCRA) is the largest global organization dedicated to combating ovarian and all gynecologic cancer. Since its founding in 1994, OCRA has invested $140 million in scientific breakthroughs, and supports 95,000 people annually through its programs, which are free to all participants. As the only dedicated voice for ovarian and gynecologic cancer on Capitol Hill, OCRA has helped to secure $3.8 billion in federal research and education funding.
